Analyst Ratings for BioNTech
Portfolio Pulse from Benzinga Insights
Analysts have provided ratings for BioNTech (NASDAQ:BNTX) in the last quarter, with 6 bullish and 10 indifferent ratings. The average price target is $141.75, compared to the current price of $107.25. This average has decreased by 1.44% from the previous average price target of $143.82.
August 04, 2023 | 9:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioNTech has received mostly bullish and indifferent ratings from analysts. The average price target suggests an upside potential.
The bullish and indifferent ratings from analysts suggest a positive outlook for BioNTech. The average price target, which is higher than the current price, indicates potential for price increase. However, the decrease in the average price target could suggest a slightly less optimistic view compared to the previous quarter.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100